Barst, R. J.
69  Ergebnisse:
Personensuche X
?
1

Haemodynamic characterisation and heart catheterisation com..:

Beghetti, M. ; Schulze-Neick, I. ; Berger, R.M.F....
International Journal of Cardiology.  203 (2016)  - p. 325-330 , 2016
 
?
 
?
3

Long-term safety and survival outcomes of patients with pul..:

Galie, N. ; Barst, R. J. ; Oudiz, R. J....
European Heart Journal.  34 (2013)  suppl 1 - p. P338-P338 , 2013
 
?
4

How has epoprostenol changed the outcome for patients with ..:

Barst, R.
International Journal of Clinical Practice.  64 (2010)  - p. 23-32 , 2010
 
?
5

A Dosing/Cross-Development Study of the Multikinase Inhibit..:

Gomberg-Maitland, M ; Maitland, M L ; Barst, R J...
Clinical Pharmacology & Therapeutics.  87 (2009)  3 - p. 303-310 , 2009
 
?
 
?
7

Guidelines for the prevention of central venous catheter-re..:

Doran, A. K. ; Ivy, D. D. ; Barst, R. J....
International Journal of Clinical Practice.  62 (2008)  - p. 5-9 , 2008
 
?
10

Hemodynamic effects of sildenafil citrate in patients with ..:

RUBIN, L ; BURGESS, G ; PARPIA, T.
American Journal of Hypertension.  18 (2005)  5 - p. A93-A94 , 2005
 
?
11

Correlation between right ventricular ejection fraction obt..:

Sobol, I ; Barst, R.J ; Nichols, K...
Journal of Nuclear Cardiology.  11 (2004)  4 - p. S25-S26 , 2004
 
?
 
?
13

Primary pulmonary hypertension: immunogenetic response to h..:

Morse, J H ; Barst, R J ; Fotino, M...
Clinical and Experimental Immunology.  106 (2003)  2 - p. 389-395 , 2003
 
?
14

Pharmacokinetics, safety, and efficacy of bosentan in pedia..:

Barst, R
Clinical Pharmacology & Therapeutics.  73 (2003)  4 - p. 372-382 , 2003
 
?
 
1-15